In conclusion, we revealed that PHF6 and JAK3 mutations cooperatively drive T-ALL progression probably via inhibiting the BAI1-MDM2-P53 signaling pathway, in addition to activating the JAK3/STAT5 signaling pathway. The gene discussed is ADGRB1; the disease is acute lymphoblastic leukemia.